Visiting Fellowship in Transcranial Magnetic Stimulation Duke University Medical Center 2017
Dates: Upcoming 2018
January 27-29, 2018
April 28-30, 2018
July 14-16, 2018
October 20-22, 2018
Course Time Schedule
Sat: 8:30am – 5:00pm
Sun: 8:30am – 7:00pm
Mon: 8:30am – 1:45pm
Duke University Medical Center (SOUTH)
40 Duke Medicine Circle, Durham, NC.
The 3-day course offers intensive training on the FDA-cleared treatment for major depression, Transcranial Magnetic Stimulation (TMS). Sponsored by the Duke University School of Medicine, it includes didactic sessions and hands-on administration of TMS. The didactic sessions with the TMS faculty from Duke University cover all topics relevant to running a TMS clinical service and a TMS research lab, including: device principles and types, motor threshold determination, treatment technique, stimulus dosing, risks, complications and contraindications, safety screening, post TMS management and continuation treatment, clinical and non-clinical research applications, and emerging brain stimulation techniques.
This activity is designed for psychiatrists, psychologists, and researchers who wish to enhance their knowledge of TMS and related brain stimulation techniques. The course session is capped at 20 participants.
At the conclusion of this activity, participants should be able to:
- State the rationale for the use of TMS in depression, anxiety disorders, schizophrenia, and other off-label conditions
- Explain regulatory issues and policies concerning TMS
- Name the two main components of transcranial magnetic stimulation devices
- Operate the TMS device and correctly use it to determine the optimal site and motor threshold
- Describe the findings from TMS research in imaging and motor cortex excitability studies
- Apply the indications for use of TMS in depression
- Identify the risks and side effects of TMS and describe how to conduct a safety screening
- Design a protocol for seizure management during TMS administration
- Outline steps necessary to set up a TMS service/lab
Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.
Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity
Planning Committee/Faculty Disclosure
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity:
Bruce Luber, PhD
Michael Olson, PAC
Simon Davis, PhD
Andrada Neacsiu, PhD
The following speaker/planning committee member has indicated that s/he has relationship(s) with industry to disclose:
- Angel V. Peterchev, PhD, Angel V. Peterchev, PhD, is inventor on patents and patent applications and has received research and travel support as well as patent royalties from Rogue Research, research and travel support, consulting fees, as well as equipment loan from Tal medical, patent application support from Magstim, as well as equipment loans from MagVenture, all related to technology for TMS.
- Sarah H. Lisanby, MD, fulfills the role of Principal Investigator for Brainsway, Magstim, Magventure, Neosync, Nexstim.
- Sandeep Vaishnavi, MD, PhD, is currently an investigator in an industry-sponsored trial of TMS for PTSD with Brainsway.
The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
For more information, please contact